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With the rapid Health care reform and increasing cost-
containment pressure on China’s health care system,
Chinese government authorities and hospital administra-
tors have focus more attention on the importance on
health economics to allocate the scarce resources more
efﬁciently. OBJECTIVE: The purpose of this study was
to identify key decision criterias and source of informa-
tion that government ofﬁcials, hospital administrators
and physicians perceive as important in drug pricing and
reimbursement process and establishing clinical practice
guidelines respectively. Moreover, obstacles to using phar-
macoeconomic evaluations in decision-making were also
identiﬁed. METHODS: Data were gathered through a
survey questionnaire administered to various members of
Health Authorities, Health Insurance Bureaus, State Food
and Drug Administrations and hospitals throughout
China. There were 390 member organisations of which
65% responded. Factor analysis CANOVA and Chi-
square test were applied. RESULTS: The ﬁndings indi-
cated that current Health care policies/guidelines supplied
by government authorities are considered the most impor-
tant source of information in decision making (mean
score 4.28) as opposed to clinical or industry input. Cost
Effectiveness arguments are considered the most impor-
tant decision criteria (mean score 4.22). Although there
was interest in pharmacoeconomics, these studies in
China were limited (90.2%) and insufﬁcient pharmaeco-
nomic knowledge among health administrators (89.0%).
There were also difﬁculties in translating study results
into practical health care administrative and clinical
usage. CONCLUSIONS: With the increasing interest and
need for Pharmacoeconomics in China’s Health care deci-
sion-making, training would be helpful in assisting gov-
ernment ofﬁcials and hospital staffs’ knowledge to make
cost-effective health care decision. Assessing global phar-
maeconomic guidelines would also be useful to pursuing
China’s pharmaeconomics interest.
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OBJECTIVES: To provide an outline of the European
Network of Health Economic Evaluation Databases
(EURO NHEED) project, whose purpose is to implement,
in 7 European centres based in France, Germany, Italy,
the Netherlands, Spain, Sweden and the United Kingdom,
databases on the economic evaluation of health care inter-
ventions. METHODS: The network is based on two
existing and well-established resources, namely the UK’s
NHS Economic Evaluation Database (NHS EED), and
France’s Connaissances et Décision en ÉConomie de la
Santé (CODECS) database. Steering and scientiﬁc com-
mittees have been established to guide methodological
and administrative developments throughout the imple-
mentation and eventual management of the project.
RESULTS: EURO NHEED is funded by the European
Commission for an initial period of 3 years, and 
covers 17 European countries. After full implementation
it will provide its users with bibliographic records, detail-
ing the main characteristics of all included studies. In
addition, structured s will be provided for articles iden-
tiﬁed as full economic evaluations (cost-beneﬁt, cost-
effectiveness or cost-utility), which will offer a detailed
critique of the ﬁndings and the methodology used. These
databases will be accessible free of charge on the Inter-
net. A common training programme has been conducted,
and a methodological guide produced which will ensure
consistency in the methods and practices adopted by 
participating centres. CONCLUSION: The EURO
NHEED project is the ﬁrst attempt to develop such a
resource on a multi-national basis. The project is bring-
ing together health economists and information scientists
from Europe and beyond to provide a number of bene-
ﬁts in the ﬁeld of Health Economics. These include har-
monisation and increased understanding regarding the
theory and methodology of economic evaluation, and
improved interpretation of the generalisability of studies.
The project will therefore advance the state of the art in
collecting, summarising, critiquing and disseminating
health economics evaluation studies conducted within
Europe.
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OBJECTIVES: In 1997, the Belgian reimbursement for
prophylaxis in surgery changed from FFS to a lump-sum
per operation. We investigate whether this altered the
medical practice w.r.t. the administration of prophylaxis.
METHODS: The entire population that had undergone
one of these six operations was included: endoscopic
resection of prostate, surgical treatment of discal hernia,
arthroplasty of hip with total prosthesis, reconstruction
of cruciate knee ligaments by arthroscopy, total hysterec-
tomy (abdominal) and total hysterectomy (vaginal),
accounting for 159,981 operations and a cost for antibi-
otics of €10853 million. Cluster analysis is performed 
to identify outliers, classify cases/patients with similar
antibiotic treatment, compare both periods, and condense
information. Different treatment patterns emerging from
the cluster analyses were examined to assess the appro-
priateness of the administered products. RESULTS: A
drastic and immediate change in medical practice: 11%
of the patients did not receive antibiotics anymore con-
trasting with the situation before, where all hospitals
administered antibiotics to all patients. Large differences
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between hospitals can be detected. Both average number
of DDD and costs dropped sharply. Cluster analyses indi-
cate that less products are used and that the number of
units administered is smaller. Concerning antimicro-
bial spectra, especially the use of second-generation
cephalosporines was reduced substantially. Further, a
large share of the prophylaxis is still not administered
according to (international) guidelines. A distinction is
made between administering too much of an appropriate
product and administering an inappropriate product. The
following percentages indicate the share of patients that
receive prophylaxis in accordance with good medical
practice: prostate: 54%; hernia: 81%, hip: 50%, cruciate
ligaments: 66%, abdominal hysterectomy: 78% and
vaginal hysterectomy: 67%. CONCLUSIONS: Both goals
of the new mechanism (reducing use and variety of
antimicrobial products in order to contain the threat of
antibiotic resistance and a reduction in costs) seem to be
accomplished. However, prophylaxis is still administered
injudiciously and inappropriately to a large share of the
patients.
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OBJECTIVE: To examine the cost of inpatient-care for
sports-related injuries resulting from a shove, collision or
tackle. METHODS: Hospital data for all reported dis-
charges in 2000 from 5 states were examined using ICD-
9 diagnosis and E-codes (E886.0) to identify the type and
circumstances of injury. These databases were used to
examine demographics, inpatient hospital costs, length 
of stay (LOS), and disposition patterns. Cost estimates
include all accommodations and ancillary services and are
reported in US$2003. Physician-related costs are not
included. Hospital charges were adjusted using a 0.61
cost-to-charge ratio and inﬂated using the appropriate
annual medical inﬂation indices of the U.S. Consumer
Price Index. RESULTS: Of the 1017 cases identiﬁed, 83%
were male. Prior to admission, 63% were treated in the
Emergency Department, 2% had ambulatory surgery and
1% spent time in an Observation Unit. The mean age was
24 years with most (56%) being less than 20 years old;
8% were <10 years. Only 4% were aged 50 years or older.
A wide variety of injuries were coded as the principal
diagnosis. Injuries recorded most frequently included
lower limb fractures (40%), upper limb fractures (24%)
and head injuries (10%). The mean total LOS was 2.3
days (median: 2, range: 1–40). The mean cost per stay
was $3,876 (median: $3,373, range: $560–$476,170).
The hospital case fatality rate was <1%. Among sur-
vivors, 97% were discharged home (4% with home
health care) and 3% required additional sub-acute inpa-
tient care (i.e., rehabilitation, skilled nursing). Managed
care organizations were the responsible payer for slightly
more than half (54%) of the cases. CONCLUSIONS:
Most of the hospitalizations for sports-related injuries
occurred among adolescents and young adults. This
analysis draws attention to the clinical and economic 
consequences of participation in sports where physical
contact with others is an integral component.
HEALTH CARE POLICY—Compliance Studies
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INTRODUCTION: Compliance is a behavior that
responds to incentives. Economic theory would suggest
that as the price of a product increases, the quantity
demanded decreases. Therefore compliance would be
altered but the exact behavioral effect is not known. This
study will examine the effects of a prescription copayment
change on one measure of compliance behavior, medica-
tion possession ratio (MPR) within two therapeutic cate-
gories SSRIs and STATINs. METHODS: The data for this
study is from a for proﬁt network model managed care
organization. On January 1, 1999 the co-payment for
prescription drugs increased by $10 in each of the 3 tiers.
The patient population was limited to individuals that
were continuously enrolled for both 1998 and 1999, in
addition to having had a minimum of 3 prescription
claims for an SSRI or STATIN in both years. The med-
ication possession ratio was deﬁned as the sum of the days
supply for all prescriptions ﬁlls divided by the number of
days of therapy between the ﬁrst prescription ﬁll and last
ﬁll, minus the days supply for the last prescription ﬁll for
each of the two years. A paired t-test was conducted
between the two years in addition, a logistic regression
model was utilized to control for appropriate independent
variables in each of the two therapeutic categories.
RESULTS: Bivariate analysis indicates that for both SSRI
(N = 142) and STATIN (N = 125) groups the MPR
decreased after the copayment increase (0.82 versus 0.76,
p < 0.0001; 0.79 versus 0.68, p < 0.0001, respectively).
The logistic regression models indicated similar results 
for the two therapeutic categories after controlling for
gender, age, median income, comorbidities, length of
therapy, and copayment change at a conﬁdence level of
0.05. CONCLUSIONS: Both bivariate and logisitic
regression indicate that an increase in copayment results
in a decrease in an individuals medication possession ratio
for SSRIs and STATINs.
